InvestSMART

Clarity Pharmaceuticals Ltd (ASX: CU6) - Announcements

- Current share price for CU6 : $1.825

ASX company news and announcements for Clarity Pharmaceuticals Ltd (CU6) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clarity Pharmaceuticals Ltd (CU6) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clarity Pharmaceuticals Ltd (CU6), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clarity Pharmaceuticals Ltd (CU6)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$681 Notification regarding unquoted securities - CU6 5 Aug 2026 4:55PM $2.700 $1.825 fallen by 32.41%
$681 SECuRE update 5 Aug 2026 10:00AM $2.620 $1.825 fallen by 30.34%
$681 Ceasing to be a substantial holder 31 Jul 2026 5:00PM $2.370 $1.825 fallen by 23%
$681 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2026 12:08PM $2.290 $1.825 fallen by 20.31%
$681 Becoming a substantial holder 30 Jul 2026 6:05PM $2.100 $1.825 fallen by 13.10%
$681 Initial Director's Interest Notice - Rossiter 16 Jul 2026 6:22PM $2.450 $1.825 fallen by 25.51%
$681 Allison Rossiter joins Clarity Board of Directors 16 Jul 2026 9:32AM $2.450 $1.825 fallen by 25.51%
$681 Ceasing to be a substantial holder 8 Jul 2026 8:23AM $2.390 $1.825 fallen by 23.64%
$681 Ceasing to be a substantial holder 7 Jul 2026 8:18AM $2.630 $1.825 fallen by 30.61%
$681 Cleansing Notice 1 Jul 2026 5:11PM $2.120 $1.825 fallen by 13.92%
$681 Application for quotation of securities - CU6 1 Jul 2026 5:05PM $2.120 $1.825 fallen by 13.92%
$681 Becoming a substantial holder 1 Jul 2026 8:18AM $2.140 $1.825 fallen by 14.72%
$681 Data on SAR-bisPSMA to be presented at EANM 29 Jun 2026 9:56AM $1.815 $1.825 risen by 0.55%
$681 Clarity celebrates 100-employee milestone 26 Jun 2026 9:36AM $2.040 $1.825 fallen by 10.54%
$681 Ceasing to be a substantial holder 25 Jun 2026 5:17PM $2.040 $1.825 fallen by 10.54%
$681 Ceasing to be a substantial holder 22 Jun 2026 5:12PM $2.030 $1.825 fallen by 10.10%
$681 Change in substantial holding 18 Jun 2026 5:21PM $2.190 $1.825 fallen by 16.67%
$681 Becoming a substantial holder 17 Jun 2026 5:56PM $2.210 $1.825 fallen by 17.42%
$681 Notification regarding unquoted securities - CU6 27 May 2026 4:41PM $2.610 $1.825 fallen by 30.08%
$681 Cleansing Notice 20 May 2026 4:57PM $2.520 $1.825 fallen by 27.58%
$681 Application for quotation of securities - CU6 20 May 2026 4:54PM $2.520 $1.825 fallen by 27.58%
$681 Clarity receives $9.8 million R&D tax incentive refund 14 May 2026 9:43AM $2.850 $1.825 fallen by 35.96%
$681 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 12:24PM $2.935 $1.825 fallen by 37.82%
$681 Change of Director's Interest Notice - Parker 22 Apr 2026 4:23PM $2.930 $1.825 fallen by 37.71%
$681 Clarity signs a Commercial Manufacturing Agreement 14 Apr 2026 8:33AM $3.130 $1.825 fallen by 41.69%

26 - 50 of 529 results

Page 2 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.